AustralianSuper Pty Ltd Has $164.92 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

AustralianSuper Pty Ltd decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 23.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 314,876 shares of the healthcare conglomerate's stock after selling 97,023 shares during the period. UnitedHealth Group comprises 0.9% of AustralianSuper Pty Ltd's portfolio, making the stock its 23rd largest holding. AustralianSuper Pty Ltd's holdings in UnitedHealth Group were worth $164,916,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Copperwynd Financial LLC lifted its holdings in shares of UnitedHealth Group by 6.5% in the first quarter. Copperwynd Financial LLC now owns 2,270 shares of the healthcare conglomerate's stock valued at $1,189,000 after purchasing an additional 139 shares in the last quarter. Calton & Associates Inc. acquired a new position in shares of UnitedHealth Group in the first quarter valued at approximately $5,080,000. Fountainhead AM LLC raised its position in shares of UnitedHealth Group by 40.2% in the first quarter. Fountainhead AM LLC now owns 691 shares of the healthcare conglomerate's stock valued at $362,000 after buying an additional 198 shares during the last quarter. FAS Wealth Partners Inc. raised its position in shares of UnitedHealth Group by 1.3% in the first quarter. FAS Wealth Partners Inc. now owns 7,149 shares of the healthcare conglomerate's stock valued at $3,744,000 after buying an additional 95 shares during the last quarter. Finally, Impact Partnership Wealth LLC acquired a new position in shares of UnitedHealth Group in the first quarter valued at approximately $888,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director owned 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders purchased 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

UNH stock traded down $0.88 on Monday, reaching $281.77. 7,652,707 shares of the company were exchanged, compared to its average volume of 7,819,495. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The stock's fifty day moving average price is $304.47 and its 200 day moving average price is $432.39. The firm has a market capitalization of $255.61 billion, a PE ratio of 11.80, a PEG ratio of 1.38 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the firm posted $6.91 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 3.14%. UnitedHealth Group's dividend payout ratio is 37.02%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. HSBC reaffirmed a "reduce" rating and set a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research report on Monday, May 19th. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday. Finally, Oppenheimer decreased their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $394.43.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.